Stack EC - Search Results

1

Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.

Smith KM, Matson S, Matson WR, Cormier K, Del Signore SJ, Hagerty SW, Stack EC, Ryu H, Ferrante RJ. Smith KM, et al. Among authors: stack ec. Biochim Biophys Acta. 2006 Jun;1762(6):616-26. doi: 10.1016/j.bbadis.2006.03.004. Epub 2006 Apr 17. Biochim Biophys Acta. 2006. PMID: 16647250 Free article.

2

Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice.

Stack EC, Kubilus JK, Smith K, Cormier K, Del Signore SJ, Guelin E, Ryu H, Hersch SM, Ferrante RJ. Stack EC, et al. J Comp Neurol. 2005 Oct 3;490(4):354-70. doi: 10.1002/cne.20680. J Comp Neurol. 2005. PMID: 16127709

3

Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice.

Stack EC, Smith KM, Ryu H, Cormier K, Chen M, Hagerty SW, Del Signore SJ, Cudkowicz ME, Friedlander RM, Ferrante RJ. Stack EC, et al. Biochim Biophys Acta. 2006 Mar;1762(3):373-80. doi: 10.1016/j.bbadis.2005.11.002. Epub 2005 Dec 5. Biochim Biophys Acta. 2006. PMID: 16364609 Free article.

4

Modulation of nucleosome dynamics in Huntington's disease.

Stack EC, Del Signore SJ, Luthi-Carter R, Soh BY, Goldstein DR, Matson S, Goodrich S, Markey AL, Cormier K, Hagerty SW, Smith K, Ryu H, Ferrante RJ. Stack EC, et al. Hum Mol Genet. 2007 May 15;16(10):1164-75. doi: 10.1093/hmg/ddm064. Epub 2007 Apr 2. Hum Mol Genet. 2007. PMID: 17403718 Free article.

5

Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice.

Stack EC, Dedeoglu A, Smith KM, Cormier K, Kubilus JK, Bogdanov M, Matson WR, Yang L, Jenkins BG, Luthi-Carter R, Kowall NW, Hersch SM, Beal MF, Ferrante RJ. Stack EC, et al. J Neurosci. 2007 Nov 21;27(47):12908-15. doi: 10.1523/JNEUROSCI.4318-07.2007. J Neurosci. 2007. PMID: 18032664 Free PMC article.

6

Huntington's disease: progress and potential in the field.

Stack EC, Ferrante RJ. Stack EC, et al. Expert Opin Investig Drugs. 2007 Dec;16(12):1933-53. doi: 10.1517/13543784.16.12.1933. Expert Opin Investig Drugs. 2007. PMID: 18042002 Review.

7

Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease.

Stack EC, Ferro JL, Kim J, Del Signore SJ, Goodrich S, Matson S, Hunt BB, Cormier K, Smith K, Matson WR, Ryu H, Ferrante RJ. Stack EC, et al. Biochim Biophys Acta. 2008 Mar;1782(3):151-62. doi: 10.1016/j.bbadis.2007.12.006. Epub 2008 Jan 16. Biochim Biophys Acta. 2008. PMID: 18206128 Free article.

8

Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants.

Stack EC, Matson WR, Ferrante RJ. Stack EC, et al. Ann N Y Acad Sci. 2008 Dec;1147:79-92. doi: 10.1196/annals.1427.008. Ann N Y Acad Sci. 2008. PMID: 19076433 Review.

9

Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage.

Fink JS, Kalda A, Ryu H, Stack EC, Schwarzschild MA, Chen JF, Ferrante RJ. Fink JS, et al. Among authors: stack ec. J Neurochem. 2004 Feb;88(3):538-44. doi: 10.1046/j.1471-4159.2003.02145.x. J Neurochem. 2004. PMID: 14720203

10

Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice.

Del Signore SJ, Amante DJ, Kim J, Stack EC, Goodrich S, Cormier K, Smith K, Cudkowicz ME, Ferrante RJ. Del Signore SJ, et al. Among authors: stack ec. Amyotroph Lateral Scler. 2009 Apr;10(2):85-94. doi: 10.1080/17482960802226148. Amyotroph Lateral Scler. 2009. PMID: 18618304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters